Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience

Treatment of hepatitis C virus (HCV) infection in patients with chronic kidney disease was difficult in the past because of the use of interferon (IFN). It was associated with high risk IFN-related adverse reactions due to reduced renal clearance of IFN. This study aimed to evaluate the antiviral ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd-Elsalam, Sherief, Abo-Amer, Yousry Esam-Eldin, El-Abgeegy, Mohamed, Elshweikh, Samah A., Elsergany, Heba Fadl, Ahmed, Rehab, Elkadeem, Mahmoud, Hawash, Nehad, Soliman, Shaimaa, Badawi, Rehab, Elguindy, Ayman Mohammed Abdou, Soliman, Moataz Yousry, Mohmed, Ahmed Abdelhaleem, Mansour, Loai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572016/
https://www.ncbi.nlm.nih.gov/pubmed/33080669
http://dx.doi.org/10.1097/MD.0000000000021972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572016/
https://www.ncbi.nlm.nih.gov/pubmed/33080669
http://dx.doi.org/10.1097/MD.0000000000021972

Ejemplares similares